Ascend Wellness Holdings (AAWH) Free Cash Flow (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Free Cash Flow came in at -$24.6 million in Q1 2026, down 1335.11% year-on-year from $2.0 million in Q1 2025, and down 173.88% quarter-over-quarter from $33.3 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Free Cash Flow (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$24.6 million for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 1335.11% year-over-year to -$24.6 million in Q1 2026; TTM through Mar 2026 was $9.3 million, a 81.01% decrease from a year earlier, with the FY2025 full-year figure at $35.9 million, down 29.26% from the prior year.
- Free Cash Flow declined to -$24.6 million in Q1 2026 per AAWH's latest filing, from $33.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $33.3 million in Q4 2025 and bottomed at -$24.6 million in Q1 2026.
- The 5-year median for Free Cash Flow is $3.7 million (2024), against an average of $5.1 million.
- Across the five-year window, Free Cash Flow soared 2331.84% in 2023 and plunged 1335.11% in 2026, its largest moves.
- Year by year, Free Cash Flow stood at -$23.1 million in 2022, then soared by 173.79% to $17.0 million in 2023, then slipped by 21.38% to $13.4 million in 2024, then soared by 148.55% to $33.3 million in 2025, then sank by 173.88% to -$24.6 million in 2026.
- Per Business Quant, the three latest AAWH Free Cash Flow figures stand at -$24.6 million (Q1 2026), $33.3 million (Q4 2025), and -$8.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | -24.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.59 Mn |
| Mar 31, 2026 | -24.59 Mn |
| Dec 31, 2025 | 33.28 Mn |
| Dec 31, 2025 | 33.28 Mn |
| Sep 30, 2025 | -8.45 Mn |
| Sep 30, 2025 | -8.45 Mn |
| Jun 30, 2025 | 9.08 Mn |
| Jun 30, 2025 | 9.08 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 13.39 Mn |
| Dec 31, 2024 | 13.39 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 32.28 Mn |
| Jun 30, 2024 | 32.28 Mn |
| Mar 31, 2024 | 3.66 Mn |
| Mar 31, 2024 | 3.66 Mn |
| Dec 31, 2023 | 17.03 Mn |
| Dec 31, 2023 | 17.03 Mn |